Washington, DC, July 26, 2017 (GLOBE NEWSWIRE) -- Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that it has been one year since the kick-off of what is widely considered the most comprehensive digital pathology workflow solution in the country at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). To help commemorate this milestone, Inspirata will be offering attendees at the APC annual meeting in Washington, DC a behind-the-scenes look at this project during a corporate workshop.
The far-reaching engagement is being implemented at OSUCCC – James and the Department for Pathology both located at The Ohio State University Wexner Medical Center in Columbus, Ohio. The end-to-end digital pathology workflow solution includes retrospective and prospective histopathology slide scanning, diagnostic cockpits for more than 50 pathologists, consultation portal, complete program and project planning as well as operational staffing, scan lab staffing, management and support.
The state-of-the-art scanning center at OSUCCC – James went online in May with the retrospective scanning portion of the project. Currently the center is scanning more than 10,500 pathology slides per week. According to Inspirata’s Senior Vice President of Digital Pathology, Sunil Singhal, “We expect this number to gradually increase to our full production capacity of scanning 21,000 slides per week once we begin the prospective scanning phase of the project.”
“While this project started off with digital pathology and the process of converting glass histology slides to digital Whole Slide Images, it has grown to involve collaboration well beyond digital pathology,” explains Inspirata CEO Satish Sanan. “We are working very closely with the cancer center on a wide range of strategic projects that will help improve access to cancer data across the institution, as well as provide workflow improvements to generate cost savings and new revenue streams.”
These adjacent projects span the development of cockpits for research, operations and a multidisciplinary tumor board, each of which leverage Inspirata’s Enterprise Service Bus and Natural Language Processing engine to access and structure longitudinal patient data from disparate sources and systems. Today, research operations and other departments at cancer centers often rely on manual processes and redundant data entry, which are inefficient, time consuming and costly for the institution.
Other initiatives Inspirata is collaborating on with OSUCCC – James include using the Crosswalk Insight: Oncology™ mobile platform to develop custom end-user applications for clinicians, staff and patients for knowledge visualization, “just in time” learning and decision support. Inspirata also is involved in several sponsored research projects, including developing predictive assays and image analytics.
“The pinnacle of all of these collaborative activities is the creation of a Cancer Information Data Trust,” continues Sanan. “Versions of the CIDT with identified and de-identified patient data will be used by different stakeholders across the cancer center for cost-of-care analyses, health management, education, research operations, biopharma discovery and clinical activities.”
Pathology leaders from OSUCCC – James will be on hand at the APC Annual Meeting as well as during the Inspirata workshop to present a behind-the-scenes look at the ongoing work taking place at the cancer center and how they got institutional buy in and funding for the project. The workshop is titled “Ushering in a New Era in Pathology: Going Digital Today,” and will be held from 3:00 – 4:30 on Thursday, July 27th in the Congressional Room at the Omni Shoreham Hotel.
About Inspirata, Inc.
Inspirata®, Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis today. The solution, which employs a unique “solution-as-a-service” business and delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data cancer repository for clinical, research and educational purposes. Its use will extend to physicians, patients, researchers and pharma among others. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit www.inspirata.com or contact info@inspirata.com.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6d9ce5c5-77f9-43f4-8e0f-18065925ec5f
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1e130039-a6a3-4c48-ba49-ed4c507facc0